Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upexi (UPXI) Asset Writedowns and Impairment (2022 - 2025)

Upexi's Asset Writedowns and Impairment history spans 4 years, with the latest figure at $229.0 for Q3 2025.

  • For Q3 2025, Asset Writedowns and Impairment changed N/A year-over-year to $229.0; the TTM value through Sep 2025 reached $1.3 million, down 24.0%, while the annual FY2024 figure was $1.8 million, N/A changed from the prior year.
  • Asset Writedowns and Impairment for Q3 2025 was $229.0 at Upexi, up from -$418030.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $1.7 million in Q2 2024 and bottomed at -$418030.0 in Q2 2025.
  • The 4-year median for Asset Writedowns and Impairment is -$3901.5 (2022), against an average of $219956.5.
  • The largest annual shift saw Asset Writedowns and Impairment crashed 327.39% in 2023 before it soared 5181.54% in 2024.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at -$8032.0 in 2022, then soared by 542.09% to $35509.0 in 2023, then surged by 4812.53% to $1.7 million in 2024, then plummeted by 99.99% to $229.0 in 2025.
  • Per Business Quant, the three most recent readings for UPXI's Asset Writedowns and Impairment are $229.0 (Q3 2025), -$418030.0 (Q2 2025), and $1.7 million (Q2 2024).